TrialOpen forum infectious diseases2025

Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19: A Randomized Controlled Trial.

Per Åkesson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.